Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 01, 2015 10:04 AM ET

Company Overview of Pancreatic Cancer Action Network, Inc.

Company Overview


United States

Key Executives for Pancreatic Cancer Action Network, Inc.

Chief Executive Officer and President
Vice President of Scientific and Medical Affairs
Compensation as of Fiscal Year 2015.

Pancreatic Cancer Action Network, Inc. Key Developments

The Pancreatic Cancer Action Network Announces Appointments to Scientific Advisory Board

The Pancreatic Cancer Action Network to welcome three new members to its prestigious Scientific Advisory Board: Sunil Hingorani, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA; Kimberly Kelly, PhD, University of Virginia, Charlottesville, VA; and Steven Leach, MD, Johns Hopkins University, Baltimore, MD. Vincent Picozzi, MD, Virginia Mason Medical Center, Seattle, WA, was appointed chair of the organization's Medical Advisory Board. Dr. Hingorani played a lead role in the development of the first genetically engineered mouse model of pancreatic cancer that accurately recapitulates the human disease. Dr. Kelly's work focuses on imaging techniques to improve early detection and diagnosis of pancreatic cancer. Based on findings funded by organization, Dr. Kelly has cofounded a biotechnology company and is currently conducting an early-phase clinical trial to test her noninvasive early detection biomarker. Dr. Leach looks at the early development of the normal pancreas to provide clues to how tumors arise. He also studies the earliest stages of pancreatic cancer initiation to discover better methods to detect and treat the disease before it has progressed to become more aggressive. Dr. Picozzi has been the principal investigator on a number of other clinical trials in pancreatic cancer. Dr. Picozzi joined the Pancreatic Cancer Action Network's Medical Advisory Board in 2008.

The Pancreatic Cancer Action Network Announces Executive Changes

The Pancreatic Cancer Action Network announced Laurie MacCaskill has been appointed Chair of the National Board of Directors of the organization, effective July 1. MacCaskill is the first pancreatic cancer patient to hold this position. The organization has also appointed Jeanne Ruesch to Vice Chair effective July 1. Ruesch serves on the board in honor of her late husband, Otto J. Ruesch.

Similar Private Companies By Industry

Company Name Region
Aurrion, Inc. United States
US Salt, LLC United States
Parsley Energy, L.P. United States
Mission Housing Delta United States
A & R Janitorial Service, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pancreatic Cancer Action Network, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at